Atengen Competitors and Similar CompaniesClear all
Atengen's competitors and similar companies include Zymeworks and Foghorn Therapeutics.
 Atengen Atengen is a biotechnology company providing a therapeutic target that is expressed specifically in tumor blood vessels of most types of solid tumors. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |
Founding Date | Founding Date 2017 | Founding Date 2003 | Founding Date 2016 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations HQ | Locations Vancouver, CA HQ Seattle, US | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 1 | Employees 45519% increase | Employees 1123% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 973.3 m | Valuation ($) 452 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $106m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income N/A | Net income ($81.1m) (FY, 2025) | Net income ($74.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 125.9m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Zymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View companyFoghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company